Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bacteriophage Therapy for Methicillin-Sensitive Staphylococcus Aureus Prosthetic Joint Infection

NCT06456424 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.

NCT NCT06456424
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06456424 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bacteriophage Therapy for Methicillin-Sensitive Staphylococcus Aureus Prosthetic Joint Infection
Lead sponsor
University of Calgary
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
November 20, 2024
Completion date
November 30, 2025
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prosthetic joint infections of hip, staphylococcus aureus infection